Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Low-grade B Cell Non-Hodgkin's Lymphoma Clinical Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of SyB L-0501 (two-day consecutive 90 mg/m2/day IV drip infusions) in combination with rituximab (375 mg/m2 IV drip infusion) on untreated, low-grade B cell non-Hodgkin's lymphoma and mantle cell lymphoma where hematopoietic stem cell transplantation is not indicated.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

• Low-grade B Cell Non-Hodgkin's Lymphoma
• Lymphoma
• Lymphoma, B-Cell
• Lymphoma, Mantle-Cell
• Lymphoma, Non-Hodgkin
• Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not Indicated

• NCT number: NCT01718691
• Study type: Interventional
• Source: SymBio Pharmaceuticals
• Status: Completed
• Phase: Phase 2